Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines.
- Author:
Kang Seuk CHOI
1
Author Information
- Publication Type:Review
- Keywords: Newcastle disease virus; Reverse genetics; Vector vaccine; Recombinant vaccine
- MeSH: Animals; Genome; Humans; Mammals; Newcastle disease virus*; Newcastle Disease*; Poultry; Reverse Genetics; RNA Viruses; Vaccines*
- From:Clinical and Experimental Vaccine Research 2017;6(2):72-82
- CountryRepublic of Korea
- Language:English
- Abstract: Recent advances in reverse genetics techniques make it possible to manipulate the genome of RNA viruses such as Newcastle disease virus (NDV). Several NDV vaccine strains have been used as vaccine vectors in poultry, mammals, and humans to express antigens of different pathogens. The safety, immunogenicity, and protective efficacy of these NDV-vectored vaccines have been evaluated in pre-clinical and clinical studies. The vaccines are safe in mammals, humans, and poultry. Bivalent NDV-vectored vaccines against pathogens of economic importance to the poultry industry have been developed. These bivalent vaccines confer solid protective immunity against NDV and other foreign antigens. In most cases, NDV-vectored vaccines induce strong local and systemic immune responses against the target foreign antigen. This review summarizes the development of NDV-vectored vaccines and their potential use as a base for designing other effective vaccines for veterinary and human use.
